Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4457 - 4464 of 11613 results
EEOC Extends Collection Period for EEO-1 Component 2 Data
October 1, 2019| Blog| Viewpoint
THE FIFTH CIRCUIT ADOPTS AN EXPANSIVE READING OF SECTION 510(b); SUBORDINATES CLAIM WITH ‘EQUITY CHARACTERISTICS’
October 1, 2019| Blog| Viewpoint
HHS Files Brief in D.C. Circuit Supporting Drug Pricing Transparency Rule
September 30, 2019| Blog| Viewpoint
East Boston Social Centers to Hold ‘Family Reunion’ Celebration Oct. 2
September 30, 2019| News
Patenting Considerations for Artificial Intelligence in Biotech and Synthetic Biology - Part 1
September 30, 2019| Blog| Viewpoint
ML Strategies Health Care Preview: Government Shutdown Looming?
September 27, 2019| Blog| Viewpoint
FTC Identifies Concerns With Plaintiff’s Lawyers Advertisements Concerning Risks Associated With Pharmaceutical Drugs
September 27, 2019| Blog| Viewpoint
MassCEC Upcoming Programs
September 27, 2019| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.